Detalhe da pesquisa
1.
Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
Gastroenterology
; 146(2): 442-52.e1, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24126097
2.
DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4.
Liver Int
; 35(1): 108-19, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24517252
3.
Infections during peginterferon/ribavirin therapy are associated with the magnitude of decline in absolute lymphocyte count: results of the IDEAL study.
Clin Infect Dis
; 58(7): 960-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24399086
4.
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection.
J Hepatol
; 61(6): 1238-46, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25064437
5.
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation.
Hepatology
; 57(5): 1752-62, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22821361
6.
In routine clinical practice, few physicians use early viral kinetics to guide HCV dual therapy treatment decisions.
Liver Int
; 34(7): e217-28, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24251988
7.
Long term changes in liver histology following treatment of chronic hepatitis C virus.
Ann Hepatol
; 13(4): 340-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24927604
8.
Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial.
Hepatology
; 55(4): 1019-29, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22030902
9.
High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials.
Hepatology
; 56(6): 2039-50, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22706730
10.
Patients with HCV and F1 and F2 fibrosis stage: treat now or wait?
Liver Int
; 33 Suppl 1: 105-10, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23286853
11.
Intensified peginterferon α-2a dosing increases sustained virologic response rates in heavy, high viral load hepatitis C genotype 1 patients with high low-density lipoprotein.
J Clin Gastroenterol
; 47(3): 271-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22951527
12.
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
J Hepatol
; 56(2): 313-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21703177
13.
Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial.
Gastroenterology
; 141(3): 900-908.e1-2, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699796
14.
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C.
Am J Gastroenterol
; 107(9): 1388-98, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22688849
15.
Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response.
Hepatology
; 54(5): 1538-46, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22045671
16.
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
Hepatology
; 53(4): 1100-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21480316
17.
Racial differences in hepatitis C treatment eligibility.
Hepatology
; 54(1): 70-8, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21488082
18.
Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?
Liver Int
; 32 Suppl 1: 54-60, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22212573
19.
Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection.
J Hepatol
; 55(1): 69-75, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21145856
20.
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin.
Gastroenterology
; 139(5): 1593-601, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20637202